Decoding the epigenetic effects of chromatin. by Festenstein, R & Aragon, L
Genome Biology 2003, 4:342
co
m
m
ent
review
s
repo
rts
depo
sited research
interactio
ns
info
rm
atio
n
refereed research
Meeting report
Decoding the epigenetic effects of chromatin
Richard Festenstein and Luis Aragon 
Address: MRC Clinical Sciences Centre, Hammersmith Hospital, Du Cane Road, London W12 ONN, UK.
Correspondence: Richard Festenstein. E-mail: r.festenstein@imperial.ac.uk
Published: 24 September 2003
Genome Biology 2003, 4:342
The electronic version of this article is the complete one and can be
found online at http://genomebiology.com/2003/4/10/342
© 2003 BioMed Central Ltd 
A report on the Alan Wolffe EMBO Workshop on
‘Chromatin and Epigenetics’, Heidelberg, Germany, 19-22
June 2003.
Alan Wolffe, who died tragically young in 2001, championed
the importance of chromatin for gene regulation throughout
his career, and this meeting was convened in his memory. As
Elizabeth Wolffe - Alan’s widow - pointed out, he realized
early on that the association of DNA with histone proteins to
form nucleosomes, the basic subunit of chromatin, was not
merely a way of packaging a large amount of DNA into the
nucleus. This meeting brought together friends and col-
leagues of Alan who are united by their fascination with how
cells use chromatin structure to regulate gene expression
and who have contributed to our understanding of how this
DNA packaging can mark genes epigenetically, thereby func-
tionally and heritably ‘labeling’ them as active or inactive. 
The dynamics of nucleosomes 
Karolin Luger (Colorado State University, Fort Collins, USA),
who pioneered studies on the structural organization of the
nucleosome, presented data on the crystal structure of nucleo-
some core particles. Using X-ray crystallography and nucleo-
some-sliding assays to investigate the effects of point mutants
of histones H3 and H4, she showed that even subtle disrup-
tions in phosphate-protein interactions correlate with
increased sliding rates of the histone octamer with respect to
DNA. She also reported that nucleosomes in which H2A was
replaced with the variant histone macroH2A (which has only
64% identity to H2A) have an overall structure very similar to
nucleosomes containing normal H2A. The differences are con-
centrated in the L1 loop of the histone, which is thought to be
important in ensuring homotypic interactions (which would
probably prevent heterodimerization of H2A and macroH2A
in the same nucleosome) and in nucleosomal dynamics. 
MacroH2A was also discussed by Stefan Dimitrov (Institut
Albert Bonniot, La Tronche, France). Previous proteomic
studies had shown macroH2A to be localized to the nucleo-
lus. Dimitrov reported that the nucleolar protein nucleolin is
required as a cofactor to allow macroH2A-containing nucleo-
somes to slide and to be remodeled by the SWI/SNF
complex. Similarly, Marco Bianchi (University Vita-Salute
San Raffaele, Milan, Italy) presented data demonstrating
that HMG B1, a high-mobility-group chromosomal protein,
facilitates nucleosomal remodeling by the ACF complex. He
showed that HMG B1 binds to the DNA just where it enters
the nucleosome (in a similar way to the linker histone H1,
which associates with the DNA connecting nucleosomes)
and may bend the DNA, thus facilitating binding of ACF.
Using the technique of fluorescence loss in photobleaching
(FLIP), he showed that HMG B1 is highly mobile in living
cells. He has also used a combination of fluorescence reso-
nance energy transfer (FRET) and photobleaching to
demonstrate that HMG B1 interacts within chromatin with
the glucocorticoid receptor, a steroid receptor and transcrip-
tion factor. In mouse embryonic fibroblasts deficient in
HMG B1 there was a reduced response to glucocorticoid. 
Moving nucleosomes in order to regulate access to the
underlying DNA involves several chromatin-remodeling
protein complexes. At present, however, it is unclear how the
remodelers induce nucleosome sliding. Two possibilities are
the twist-diffusion and looping models; the twist-diffusion
model proposes that the DNA screws along the surface of the
histone octamer, whereas the looping model suggests that
first an internal loop forms and this then translocates
around the nucleosome. Jeffrey Hayes (University of
Rochester Medical Center, New York USA) has provided evi-
dence against the twist-diffusion model by showing that the
human Mi-2 and SWI/SNF chromatin-remodeling complexes
can still remodel a positioned nucleosome for which hairpins,
flaps and nicks had been introduced into the nucleosomal
DNA. Carl Wu (National Cancer Institute, Bethesda, USA)
presented evidence that the Drosophila nucleosome sliding
complex NURF is required for transcriptional activation or
repression in vivo. He also showed that mutations of the
genes encoding Nurf301 or Iswi (both components of the
NURF complex) cause neoplastic transformation of blood
cells. Using microarrays, Wu has identified potential candi-
date genes that are not expressed correctly in nurf301
mutants and could therefore be responsible for the trans-
formed phenotype. Biochemical and genetic studies of the
INO80 complex (a new chromatin-remodeling enzyme)
revealed that the actin-related proteins Arp5 and Arp8 par-
ticipate in chromatin remodeling, possibly by acting as chap-
erones for histones H3 and H4.
The dynamics of higher-order chromatin
It is becoming increasingly clear that interphase chromatin is
highly dynamic and functionally compartmentalized. David
Clark (National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDKD), Bethesda, USA) reported that induction
of the Saccharomyces cerevisiae HIS3 gene (which encodes a
selectable marker) is accompanied by a large scale SWI/SNF-
dependent remodeling of chromatin that was indicated by a
dramatic loss of nucleosomal supercoiling, a decompaction of
the chromatin and a general increase in the accessibility of the
chromatin to restriction enzymes. He found that the chromatin
remodeling that occurred upon activation of the gene was not
restricted to the promoter but involved the whole HIS3
reporter gene. Susan Gasser (University of Geneva, Switzer-
land) presented an elegant approach to the study of interphase
chromatin dynamics. She has used in vivo tagging of yeast
chromosomes and video microscopy to show that transcribed
chromosomal regions are highly mobile (with quick step move-
ments of up to 0.5 m) but are constrained to defined sub-
nuclear regions. In contrast, the yeast telomeres and
centromeres move in a very restricted area near the nuclear
envelope. The mobility of transcribed regions was energy-
dependent and was not reduced by inhibition of transcriptional
elongation, but was increased either by rapamycin (an inhibitor
of elongation) or by the viral transcriptional activator VP16
(which could potentially recruit SWI/SNF complexes). These
data suggest that chromatin remodelers such as the SWI/SNF
complex are responsible for the high mobility of chromatin. 
Wendy Bickmore (MRC Human Genetics Unit, Edinburgh,
UK) has used a novel approach to study the higher-order chro-
matin structure of mammalian chromosomes. She separated
‘open’ and ‘closed’ forms of chromatin on sucrose gradients and
hybridized the resulting fractions to mammalian metaphase
chromosome spreads and microarrays of the whole human
genome. Her data reveal a strong correlation between tran-
scriptionally active regions and an open chromatin conforma-
tion. She also showed a correlation between nuclear location
and activation of a mammalian Hox gene cluster. After induc-
tion of embryonic stem (ES) cells to differentiate, this gene
cluster was located outside its normal chromosome territory. 
It has been proposed that controlled movement of chromatin
regions is linked to the regulation of gene expression during
development. Along these lines, Frank Grosveld (Erasmus Uni-
versity, Rotterdam, The Netherlands) described direct and
dynamic interactions between specific DNase I-hypersensitive
sites (HS) of the human -globin locus control region (LCR)
and the promoters within the -globin locus during develop-
ment; on the basis of these and other findings he has formu-
lated an ‘active chromatin hub’ model that takes into account
the organization of the -globin locus in four dimensions
(space and time). Moreover, he has shown, for the first time in
mammals, that early in development, but not in the adult, the
LCR HS 5 can act as a barrier to spreading of what is thought to
be heterochromatin. Gary Felsenfeld (NIDDKD), who first
described the -globin insulator element (LCR HS 4) in the
chicken, presented data delineating two of its properties: its
ability to inhibit enhancer-promoter interactions and to protect
against repressive chromosomal position effects. He showed
previously that the insulator-binding protein factor CTCF is
required for the blocking of enhancer-promoter interactions,
and he has now identified -globin protein 1 (BGP1) as a poten-
tial candidate effector of the insulator’s barrier function.
Barrier function was also the focus of a talk by Andreas
Ladurner (European Molecular Biology Laboratory (EMBL),
Heidelberg, Germany). He has investigated the role of the
bromodomain protein Bdf1p in S. cerevisiae and described
how Bdf1p protects acetylated histones H3 and H4 from the
Sir2p deacetylase, thereby preventing the spreading of hetero-
chromatin at telomeres and at the mating-type locus. Using
chromatin immunoprecipitation (ChIP), he also showed that
promoters of genes that normally bind Bdf1p fail to do so in
Bdf1 mutants. Because the binding of Sir3p (a component of
transcriptionally repressed heterochromatin in S. cerevisiae)
to chromatin extends from telomeric heterochromatin into
euchromatin in Bdf1 mutant cells, he suggested that Bdf1p
might act as a heterochromatin-euchromatin buffer.
Wolfram Hörz (University of Munich, Germany) presented
data revealing a seemingly paradoxical reduction in histone
acetylation following gene induction, contrasting with other
observations that histone acetylation occurs at transcription-
ally active loci. Using yeast strains in which mutations in
genes encoding the SWI/SNF complex had caused a delay in
activation kinetics, he found that, in fact, transient hyper-
acetylation occurred, followed by a rapid loss of histones,
thereby allowing upregulation of gene expression. A similar
finding was presented by Saadi Khochbin (Institut Albert
Bonniot), who reported that during the formation of sperm,
an increase in histone modifications (histone acetylation and
methylation) also preceded histone loss. He also identified a
potential function for a gene encoding a protein, BRDT,
containing two bromodomains. BRDT is specifically
expressed in late spermiogenesis and can condense hyper-
acetylated chromatin in vitro, thus providing a substrate for
histone degradation followed by replacement.
342.2 Genome Biology 2003, Volume 4, Issue 10, Article 342 Festenstein and Aragon http://genomebiology.com/2003/4/10/342
Genome Biology 2003, 4:342
Little is known about the DNA sequence requirements for
recruiting heterochromatin-mediated silencing in mammals.
One of us (R.F.), having previously shown that pericentromeric
silencing in mice could be overcome by the human CD2 LCR,
showed at the meeting that the short DNA triplet-repeat
expansions found in several human diseases can recruit
heterochromatin protein 1 (HP1)-sensitive position-effect
variegation at multiple sites in the mouse genome. It was also
reported that HP1 is highly mobile in the constitutive hetero-
chromatin of living T cells, as detected using fluorescence
recovery after photobleaching (FRAP), and that this mobility is
increased by immune activation, indicating potential plasticity
in the maintenance of heterochromatin domains. Furthermore,
late replication of transgene DNA in S phase in T cells corre-
lated with heterochromatin-mediated silencing.
The link between DNA replication and gene expression was
also highlighted in the talk by Marcel Mechali (Institute of
Human Genetics, CNRS, Montpellier, France), who
described experiments suggesting that although the specifi-
cation of mammalian replication origins needs components
of the transcriptional machinery, transcription itself is not
necessary. He proposed that such ‘epigenetic specifications’
might contribute to the regulated formation of chromatin
domains (for example in the Hox gene clusters). Continuing
the DNA-replication theme, Ron Laskey (Hutchinson/MRC
Research Centre, Cambridge, UK) presented striking data
indicating that the unwinding of chromatin at the replication
fork could be mediated by proteins that rotate the double
helix at a more distant location than the replication fork
itself. He also showed, using fluorescence microscopy, that
the MCM proteins (components of the replication machin-
ery) could be used as an accurate diagnostic tool for cancer. 
RNA mechanisms in epigenetic silencing
The emerging evidence for a role of RNA interference
(RNAi) in chromatin-mediated silencing has aroused much
excitement. Renato Paro (University of Heidelberg,
Germany) suggested a link between intergenic transcription
in Drosophila and Polycomb-mediated silencing (Polycomb
is a protein complex that binds to Hox genes, maintaining
them in an inactive state), and suggested that this might be
due to an underlying RNAi mechanism. He has developed a
bioinformatic approach that has identified 167 candidate
sequences capable of recruiting either Polycomb (Polycomb
response elements or PREs) or Trithorax (the functional
antagonist of Polycomb which binds at Trithorax response
elements, TREs), several of which were in clusters. 
Robin Allshire (The Wellcome Trust Centre for Cell Biology,
Edinburgh, UK) presented experiments that establish a link
between heterochromatin-mediated gene silencing and RNAi
in Schizosaccharomyces pombe. He was able to repress
reporter-gene expression in trans using a complementary
hairpin RNA transgene that was homologous to the reporter.
Using genetics, he found that silencing was dependent on
Clr4 (a homolog of the mammalian and Drosophila Suvar39
histone methyltransferase) and involved recruitment of Swi6
(a homolog of HP1, a key component of heterochromatin). To
determine whether this mechanism operates normally in
wild-type yeast, he looked for and found a correlation
between silencing and the proximity of genes to naturally
occurring inverted long terminal repeats (LTRs); such
repeats generate hairpin RNAs that can cause RNAi. 
Asifa Akthar (EMBL) had previously shown that the binding
of the chromodomain-containing protein Mof1, which is
involved in dosage compensation of gene expression from
the male X chromosome in Drosophila, is sensitive to RNase
treatment. She presented new data showing that not only
Mof1, but also Msl3 (but not Msl1), was apparently depen-
dent on RNA for X-chromosome localization in Drosophila
males. Like Mof1, Msl3 and Msl1 are components of the
male-specific lethal (MSL) complex associated with the male
X chromosome. In addition, she showed that acetylation of
Msl3 at a specific lysine was mediated by Mof1 in vitro, and
that increased global acetylation induced in vivo by the
potent histone deacetylase inhibitor trichostatin A decreased
the localization of Msl3 to the X chromosome. This acetyla-
tion prevented binding of Msl3 to an RNA component of the
dosage-compensation machinery, Rox2. Continuing the
dosage-compensation theme, Edith Heard (Curie Institute,
CNRS, Paris, France) presented interesting data on the tem-
poral regulation of chromatin modifications during female X
inactivation in mammals. Using mouse embryos, she
showed that X inactivation is initiated much earlier in devel-
opment than previously thought and well before the first
overt signs of differentiation (the appearance of trophecto-
derm cells at the blastocyst stage). She has shown that
coating of the paternal X chromosome with Xist RNA at the
four-cell stage is followed by exclusion of RNA polymerase II
and a simultaneous decrease in acetylation of histone H3 on
lysine 9 and in di-methylation of histone H3 on lysine 4, all
occurring at the eight-cell stage. From the 16-cell stage
onwards, association of Eed/Enx1 (a Polycomb complex con-
taining a histone methyltransferase) begins with both di-
methylation of histone H3 on lysine 9 and tri-methylation of
histone H3 on lysine 27. This sequence of events provides
essential information for understanding X inactivation. 
Methylation of DNA and histone H3 
Adrian Bird (Institute of Cell and Molecular Biology, Edin-
burgh, UK) reviewed the in vivo functions of the DNA
methyl-binding gene (MBD) family in mice, as revealed by
gene knockouts. Whereas the knockout of the MBD protein
MECP2 in mice mirrored the human Rett syndrome, the
knockout of MBD2 (a component of MECP1, the methyl-
DNA-binding chromatin-remodeling complex) resulted in
maternal disinterest, an inability to repress a methylated
transgene reporter, derepression of the interleukin-4 gene in
co
m
m
ent
review
s
repo
rts
depo
sited research
interactio
ns
info
rm
atio
n
refereed research
http://genomebiology.com/2003/4/10/342                                     Genome Biology 2003, Volume 4, Issue 10, Article 342 Festenstein and Aragon  342.3
Genome Biology 2003, 4:342
helper T cells, partial derepression of Xist and a dose-
dependent effect on intestinal tumor burden (equivalent to
the effect of knocking out the DNA methyltransferase
Dnmt1). Wolf Reik (The Babraham Institute, Cambridge,
UK) described the use of fluorescence microscopy to show
that the erasure of DNA methylation that takes place imme-
diately after fertilization in mouse embryos is highly variable
and often grossly impaired in ‘cloned’ embryos, providing a
potential explanation for the low efficiency of cloning.
Thomas Jenuwein (Research Institute of Molecular Pathology,
Vienna, Austria) clarified the function of the mouse SUV39H
and G9a histone methyltransferases using antibodies
directed against histone H3 mono-, di- or tri-methylated at
lysine 9. He showed that SUV39H could di- and tri-methylate
H3 lysine 9 in vitro and that pericentromeric heterochromatin
was tri-methylated. In contrast, G9a appeared incapable of tri-
methylation on this residue. Data presented by Jürg Mueller
(EMBL) suggested that the histone methyltransferases Trx and
Ash1, which methylate lysine 4 of histone H3 in Drosophila,
are needed to counteract Polycomb-mediated silencing but are
not needed for transcriptional activation per se.
It was clear from this meeting that we have begun to decipher
the epigenetic mechanisms that help cells ‘remember’ which
genes should be activated or silenced. Hope was expressed
by the organizers that this meeting would be the first of a
regular series, perhaps alternating with the bi-annual
Gordon Conference in Epigenetics, which takes place in New
Hampshire (USA). 
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